The former officials say the agency's plan to revamp how vaccines for flu, Covid and other respiratory viruses are handled ...
Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...
Twelve former U.S. FDA commissioners said on Wednesday they were deeply concerned about proposed changes to U.S. vaccine ...
A recent memo from an FDA vaccine division director has reignited debate about COVID-19 immunization for children. The ...
With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...
FDA chief medical officer Vinay Prasad told reporters that the agency would be changing its vaccine approval process.
Shares of BioNTech, the German vaccine innovator, came under significant pressure on a pivotal Tuesday. The sell-off, which ...
According to DataM Intelligence, the Respiratory Syncytial Virus (RSV) Market Size reached USD 1.95 billion in 2024 and is projected to advance to USD 4.54 billion by 2033, expanding at a strong CAGR ...
WASHINGTON, DC – Dr Vinay Prasad, the Food and Drug Administration’s vaccine chief, ignited a political and scientific ...
Shares of Moderna and BioNTech fell on Monday, likely in response to a FDA official's memo outlining a link between COVID-19 mRNA vaccines and myocarditis deaths in 10 children. Concern about that ...
A top FDA official has proposed broad changes to the review and approval process for vaccines, citing a new internal review linking the deaths of 10 children to COVID-19 vaccines. In an internal memo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback